‘Medicine safety is in the DNA of pharmacists.’


The PSA has welcomed new data highlighting the importance of hospital pharmacists in medicines charting

The study, published this week in the British Journal of Clinical Pharmacology, looked at a collaborative model between pharmacists and doctors to reduce medication errors and length of hospital stay.

It found that partnered pharmacist medication charting reduced inpatient stay from 4.7 to 4.2 days, and was associated with a reduction in the proportion of patients with at least one medication error.

“Medicine safety is in the DNA of pharmacists. It is not surprising that when hospital pharmacists are more involved in taking a medicine history and charting medicines that patients are safer, and that this leads to shorter hospital stays,” Pharmaceutical Society of Australia National President A/Prof Chris Freeman said.

“On top of the obvious benefit of patients being safer and getting home sooner, there are clear financial benefits to our stretched health system from patients experiencing shorter hospital stays which stem from higher-quality episodes of care.

“Models of care like this pharmacist-led medicines charting initiative need to become normal care for all patients in all hospitals if we are serious about medicine safety.  

“Whatever Australian hospital a patient is in, they deserve to receive access to high quality pharmacist care like this.

“We welcome this research as it adds further weight to PSA’s call in Pharmacists in 20232 for hospital pharmacists to be available at comparable levels regardless of location, timing or nature of stay to make patients in Australian hospitals safer.”

Previous ‘Pharmacists are not practising to the full extent of their training.’
Next Polio on its way out

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.